Drug intelligence / Profile preview

Nystaform HC

Development stage
Unknown
Lead developer
Typharm
Modality
Small Molecules
Administration
Topical
01

Overview

Nystaform HC is a topical combination medication developed by Typharm Limited, specifically formulated to treat inflammatory skin conditions complicated by fungal and bacterial infections. The product contains three active ingredients: nystatin, a polyene antifungal that disrupts fungal cell membranes by binding to ergosterol; hydrocortisone, a mild corticosteroid that acts as a glucocorticoid receptor agonist to reduce inflammation, itching, and redness; and chlorhexidine, an antibacterial agent that provides broad-spectrum activity against various bacteria. It is indicated for the treatment of infected dermatoses such as ringworm (tinea corporis), athlete's foot (tinea pedis), and infected nappy rash. Nystaform HC is available in both cream and ointment formulations for topical application.

Brand names
Nystaform HC
Other names
nystatin + hydrocortisone + chlorhexidine
02

Targets

ErgosterolGR (Glucocorticoid receptor)PGN (Peptidoglycan)

Beyond the preview

Go deeper on Nystaform HC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nystaform HC.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call